For an appointment call (877) 692-3443
Join our Mailing List
Enter Your Information

If you would like to receive information from the Center for Advanced Digestive Care, including patient newsletters, events and information on new programs at the CADC, please subscribe to our mailing list.

* First Name

* Last Name

* Email Address:

Zip Code

* Required field

Center for Advanced Digestive Care

By clicking "Subscribe" you agree to receive information as selected above from NewYork-Presbyterian Hospital. NewYork-Presbyterian
respects your privacy and will not sell, rent, or give away your information to any third party.

Mailing List

Learn how the CADC is transforming patient care. Read our PDF brochures:

  • Overview
  • For Children
  • For Adults

overview of care

overview of care for children

overview of care for adults

Advanced Endoscopic Care

Pancreas Brochure

Pancreas Brochure

Download Your Personal Wellness Guide - Ileostomy

Personal Care Guide


Mailing List
Patient Newsletter Volume One Number Four

Volume 1, Issue 4.
Make That Call for Colon Cancer Screening

Patient Newsletter Volume One Number Three

Volume 1, Issue 3.
NEJM Study finds Bariatric Surgery Dramatically Outperforms Standard Treatment for Type 2 Diabetes

Winter Update 2011

Welcoming new faculty to NewYork-Presbyterian/ Weill Cornell Medical Center ...


Mailing List

In a Q&A with the New York Times, Dr. Christine Frissora elaborates on how probiotics work and possible risks.NY Times

Dr. Robbyn Sockolow receives the Crohn’s & Colitis Foundation of America’s 2014 Woman of Distinction in Medicine honor.CCFA

Advancements in stool sampling allow for improved cancer detection accuracy. Dr. Felice Schnoll-Sussman weighs in.NBC News

Dr. Frissora explains the pros and cons of probiotics.NY1 News

Dr. Felice Schnoll-Sussman talks with Katie Couric about the risk factors and warning signs of Colon Cancer.On Katie

Dr. Frissora weighs in on how chocolate can play a positive role in one's diet. ABC News

A new treatment for difficult-to-treat hepatitis C has higher cure rates, takes less time and causes fewer side effects than the current therapy, read more about the new research led by Dr. Ira Jacobson